John Wells
@Weil Company, Inc.
Latest period2024 - Q3ReportedManaged Assets$305.068MTotal holdings142
Assets growth rate11.32%Assets growth rate (2-Q avg)10.03%Continuous growth in asset value4 quarters
Portfolio positions
This chart displays the top 10 holdings in Weil Company, Inc.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 142 positions.
Assets under management
The assets under management (AUM) of Weil Company, Inc. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 305.068M in assets, with a quarterly growth rate of 11.32% and a 2-quarter average growth rate of 10.03%. The portfolio is managed by John Wells, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
RSPInvesco Exchange Traded Fd T
| 2.07% | $6.304M 35,187 shares@ $179.17 avg price | Increased 4.6% |
BRK.ABerkshire Hathaway Inc Del
| 2.04% | $6.221M 9 shares@ $691180.0 avg price | |
METAMeta Platforms Inc
| 1.9% | $5.789M 10,113 shares@ $572.43 avg price | Decreased -6.36% |
HLIHoulihan Lokey Inc
| 1.81% | $5.497M 34,788 shares@ $158.03 avg price | Decreased -12.1% |
GOOGLAlphabet Inc
| 1.6% | $4.862M 29,317 shares@ $165.85 avg price | Decreased -2.21% |
MKLMarkel Group Inc
| 1.59% | $4.844M 3,088 shares@ $1568.58 avg price | Increased 1.28% |
MDYSpdr S&p Midcap 400 Etf Tr
| 1.44% | $4.388M 7,702 shares@ $569.7 avg price | Decreased -4.06% |
UTHRUnited Therapeutics Corp Del
| 1.39% | $4.23M 11,803 shares@ $358.35 avg price | Decreased -14.5% |
CBChubb Limited
| 1.35% | $4.114M 14,267 shares@ $288.39 avg price | Increased 0.03% |
JPMJpmorgan Chase & Co.
| 1.33% | $4.032M 19,123 shares@ $210.87 avg price | Decreased -13.72% |